Industry Experts

Shalom Goldberg is a Director at J&J in Global Discovery Chemistry where he leads a team focused on discovery of bioconjugates including ADCs, radioligand therapies, and siRNA conjugates. He has significant experience in bioconjugation chemistry and design of optimized bioconjugate molecules.